Literature DB >> 30552022

Simultaneous Loss of Both Atypical Protein Kinase C Genes in the Intestinal Epithelium Drives Serrated Intestinal Cancer by Impairing Immunosurveillance.

Yuki Nakanishi1, Angeles Duran1, Antoine L'Hermitte1, Phillip M Shelton1, Naoko Nakanishi1, Miguel Reina-Campos2, Jianfeng Huang1, Ferran Soldevila3, Bas J G Baaten3, Daniele V F Tauriello4, Elias A Castilla1, Munveer S Bhangoo5, Fei Bao6, Darren Sigal5, Maria T Diaz-Meco1, Jorge Moscat7.   

Abstract

Serrated adenocarcinoma, an alternative pathway for colorectal cancer (CRC) development, accounts for 15%-30% of all CRCs and is aggressive and treatment resistant. We show that the expression of atypical protein kinase C ζ (PKCζ) and PKCλ/ι was reduced in human serrated tumors. Simultaneous inactivation of the encoding genes in the mouse intestinal epithelium resulted in spontaneous serrated tumorigenesis that progressed to advanced cancer with a strongly reactive and immunosuppressive stroma. Whereas epithelial PKCλ/ι deficiency led to immunogenic cell death and the infiltration of CD8+ T cells, which repressed tumor initiation, PKCζ loss impaired interferon and CD8+ T cell responses, which resulted in tumorigenesis. Combined treatment with a TGF-β receptor inhibitor plus anti-PD-L1 checkpoint blockade showed synergistic curative activity. Analysis of human samples supported the relevance of these kinases in the immunosurveillance defects of human serrated CRC. These findings provide insight into avenues for the detection and treatment of this poor-prognosis subtype of CRC.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PKCζ; PKCλ/ι; TGF-β; atypical PKCs; colorectal cancer; immunosuppression; immunosurveillance; interferon; intestinal inflammation; serrated adenocarcinoma

Mesh:

Substances:

Year:  2018        PMID: 30552022      PMCID: PMC6301096          DOI: 10.1016/j.immuni.2018.09.013

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  22 in total

1.  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

Authors:  Katherine B Chiappinelli; Pamela L Strissel; Alexis Desrichard; Huili Li; Christine Henke; Benjamin Akman; Alexander Hein; Neal S Rote; Leslie M Cope; Alexandra Snyder; Vladimir Makarov; Sadna Budhu; Sadna Buhu; Dennis J Slamon; Jedd D Wolchok; Drew M Pardoll; Matthias W Beckmann; Cynthia A Zahnow; Taha Merghoub; Taha Mergoub; Timothy A Chan; Stephen B Baylin; Reiner Strick
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

Review 2.  Antitumour actions of interferons: implications for cancer therapy.

Authors:  Belinda S Parker; Jai Rautela; Paul J Hertzog
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

Review 3.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

Review 4.  Immunogenic cell death in cancer and infectious disease.

Authors:  Lorenzo Galluzzi; Aitziber Buqué; Oliver Kepp; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2016-10-17       Impact factor: 53.106

Review 5.  Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes.

Authors:  Michael S Lee; David G Menter; Scott Kopetz
Journal:  J Natl Compr Canc Netw       Date:  2017-03       Impact factor: 11.908

6.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

Authors:  Dung T Le; Jennifer N Uram; Hao Wang; Bjarne R Bartlett; Holly Kemberling; Aleksandra D Eyring; Andrew D Skora; Brandon S Luber; Nilofer S Azad; Dan Laheru; Barbara Biedrzycki; Ross C Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Steven M Duffy; Richard M Goldberg; Albert de la Chapelle; Minori Koshiji; Feriyl Bhaijee; Thomas Huebner; Ralph H Hruban; Laura D Wood; Nathan Cuka; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; Shibin Zhou; Toby C Cornish; Janis M Taube; Robert A Anders; James R Eshleman; Bert Vogelstein; Luis A Diaz
Journal:  N Engl J Med       Date:  2015-05-30       Impact factor: 91.245

7.  Stromal contribution to the colorectal cancer transcriptome.

Authors:  Claudio Isella; Andrea Terrasi; Sara Erika Bellomo; Consalvo Petti; Giovanni Galatola; Andrea Muratore; Alfredo Mellano; Rebecca Senetta; Adele Cassenti; Cristina Sonetto; Giorgio Inghirami; Livio Trusolino; Zsolt Fekete; Mark De Ridder; Paola Cassoni; Guy Storme; Andrea Bertotti; Enzo Medico
Journal:  Nat Genet       Date:  2015-02-23       Impact factor: 38.330

8.  Control of Paneth Cell Fate, Intestinal Inflammation, and Tumorigenesis by PKCλ/ι.

Authors:  Yuki Nakanishi; Miguel Reina-Campos; Naoko Nakanishi; Victoria Llado; Lisa Elmen; Scott Peterson; Alex Campos; Surya K De; Michael Leitges; Hiroki Ikeuchi; Maurizio Pellecchia; Richard S Blumberg; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cell Rep       Date:  2016-09-20       Impact factor: 9.423

9.  A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.

Authors:  Masayuki Fujii; Mariko Shimokawa; Shoichi Date; Ai Takano; Mami Matano; Kosaku Nanki; Yuki Ohta; Kohta Toshimitsu; Yoshihiro Nakazato; Kenta Kawasaki; Toshio Uraoka; Toshiaki Watanabe; Takanori Kanai; Toshiro Sato
Journal:  Cell Stem Cell       Date:  2016-05-19       Impact factor: 24.633

10.  RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers.

Authors:  Don A Delker; Brett M McGettigan; Priyanka Kanth; Stelian Pop; Deborah W Neklason; Mary P Bronner; Randall W Burt; Curt H Hagedorn
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

View more
  19 in total

Review 1.  The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

Authors:  Miguel Reina-Campos; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cancer Cell       Date:  2019-08-29       Impact factor: 31.743

2.  Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer.

Authors:  Miguel Reina-Campos; Juan F Linares; Angeles Duran; Thekla Cordes; Antoine L'Hermitte; Mehmet G Badur; Munveer S Bhangoo; Phataraporn K Thorson; Alicia Richards; Tarmo Rooslid; Dolores C Garcia-Olmo; Syongh Y Nam-Cha; Antonio S Salinas-Sanchez; Ken Eng; Himisha Beltran; David A Scott; Christian M Metallo; Jorge Moscat; Maria T Diaz-Meco
Journal:  Cancer Cell       Date:  2019-02-28       Impact factor: 31.743

Review 3.  Serrated Colorectal Cancer: The Road Less Travelled?

Authors:  Yuki Nakanishi; Maria T Diaz-Meco; Jorge Moscat
Journal:  Trends Cancer       Date:  2019-10-28

4.  PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression.

Authors:  Yotaro Kudo; Masayuki Sugimoto; Esperanza Arias; Hiroaki Kasashima; Thekla Cordes; Juan F Linares; Angeles Duran; Yuki Nakanishi; Naoko Nakanishi; Antoine L'Hermitte; Alex Campos; Nadia Senni; Tarmo Rooslid; Lewis R Roberts; Ana Maria Cuervo; Christian M Metallo; Michael Karin; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cancer Cell       Date:  2020-06-25       Impact factor: 31.743

Review 5.  Overcoming TGFβ-mediated immune evasion in cancer.

Authors:  Daniele V F Tauriello; Elena Sancho; Eduard Batlle
Journal:  Nat Rev Cancer       Date:  2021-10-20       Impact factor: 60.716

Review 6.  The inflammatory pathogenesis of colorectal cancer.

Authors:  Mark Schmitt; Florian R Greten
Journal:  Nat Rev Immunol       Date:  2021-04-28       Impact factor: 53.106

7.  PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis.

Authors:  Juan F Linares; Xiao Zhang; Anxo Martinez-Ordoñez; Angeles Duran; Hiroto Kinoshita; Hiroaki Kasashima; Naoko Nakanishi; Yuki Nakanishi; Ryan Carelli; Luca Cappelli; Esperanza Arias; Masakazu Yashiro; Masaichi Ohira; Sanjay Patel; Giorgio Inghirami; Massimo Loda; Ana Maria Cuervo; Maria T Diaz-Meco; Jorge Moscat
Journal:  Mol Cell       Date:  2021-09-23       Impact factor: 17.970

Review 8.  Equivocal, explicit and emergent actions of PKC isoforms in cancer.

Authors:  Peter J Parker; Sophie J Brown; Veronique Calleja; Probir Chakravarty; Mathias Cobbaut; Mark Linch; Jacqueline J T Marshall; Silvia Martini; Neil Q McDonald; Tanya Soliman; Lisa Watson
Journal:  Nat Rev Cancer       Date:  2020-11-11       Impact factor: 60.716

9.  Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population.

Authors:  Hiroaki Kasashima; Angeles Duran; Anxo Martinez-Ordoñez; Yuki Nakanishi; Hiroto Kinoshita; Juan F Linares; Miguel Reina-Campos; Yotaro Kudo; Antoine L'Hermitte; Masakazu Yashiro; Masaichi Ohira; Fei Bao; Daniele V F Tauriello; Eduard Batlle; Maria T Diaz-Meco; Jorge Moscat
Journal:  Dev Cell       Date:  2020-11-17       Impact factor: 12.270

10.  Pre-clinical modelling of rectal cancer to develop novel radiotherapy-based treatment strategies.

Authors:  Michael A Gillespie; Colin W Steele; Tamsin R M Lannagan; Owen J Sansom; Campbell S D Roxburgh
Journal:  Oncol Rev       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.